CME Group (CME) Stock Rating Reaffirmed by Deutsche Bank

CME Group (NASDAQ:CME)‘s stock had its “buy” rating reissued by stock analysts at Deutsche Bank in a research report issued to clients and investors on Thursday. They currently have a $192.00 target price on the financial services provider’s stock, up from their previous target price of $185.00. Deutsche Bank’s target price suggests a potential upside of 8.78% from the company’s current price.

Other analysts have also recently issued research reports about the company. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 28th. Jefferies Financial Group reaffirmed a “buy” rating and set a $190.00 price target on shares of CME Group in a research report on Wednesday, September 5th. Zacks Investment Research raised CME Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 3rd. Berenberg Bank set a $184.00 price target on CME Group and gave the stock a “hold” rating in a research report on Thursday, September 20th. Finally, Wells Fargo & Co lifted their price target on CME Group from $170.00 to $175.00 and gave the stock a “market perform” rating in a research report on Monday, July 9th. Five investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. CME Group presently has a consensus rating of “Buy” and a consensus target price of $178.93.

CME traded up $0.47 on Thursday, reaching $176.50. 1,734,102 shares of the stock were exchanged, compared to its average volume of 1,566,127. CME Group has a fifty-two week low of $132.33 and a fifty-two week high of $182.97. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.08 and a current ratio of 1.08. The stock has a market cap of $57.79 billion, a P/E ratio of 37.00, a P/E/G ratio of 3.20 and a beta of 0.64.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, July 26th. The financial services provider reported $1.74 EPS for the quarter, topping the Zacks’ consensus estimate of $1.72 by $0.02. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The company had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the previous year, the firm posted $1.22 EPS. The firm’s revenue was up 14.6% compared to the same quarter last year. Analysts predict that CME Group will post 6.64 EPS for the current fiscal year.

In other CME Group news, President Bryan T. Durkin sold 11,509 shares of CME Group stock in a transaction dated Monday, August 6th. The stock was sold at an average price of $162.01, for a total transaction of $1,864,573.09. Following the completion of the transaction, the president now owns 64,862 shares in the company, valued at approximately $10,508,292.62. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Jack J. Tobin sold 7,820 shares of CME Group stock in a transaction dated Wednesday, September 5th. The shares were sold at an average price of $174.87, for a total value of $1,367,483.40. Following the transaction, the chief accounting officer now owns 17,534 shares of the company’s stock, valued at approximately $3,066,170.58. The disclosure for this sale can be found here. Insiders have sold a total of 26,688 shares of company stock valued at $4,523,957 in the last quarter. Company insiders own 0.43% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CME. Janus Henderson Group PLC increased its stake in shares of CME Group by 13.2% in the 2nd quarter. Janus Henderson Group PLC now owns 6,129,157 shares of the financial services provider’s stock valued at $1,004,691,000 after purchasing an additional 716,655 shares in the last quarter. Renaissance Technologies LLC purchased a new position in shares of CME Group in the 2nd quarter valued at about $96,350,000. Unigestion Holding SA purchased a new position in shares of CME Group in the 2nd quarter valued at about $96,251,000. KAMES CAPITAL plc purchased a new position in shares of CME Group in the 2nd quarter valued at about $85,187,000. Finally, Standard Life Aberdeen plc increased its stake in shares of CME Group by 38.1% in the 2nd quarter. Standard Life Aberdeen plc now owns 1,765,929 shares of the financial services provider’s stock valued at $289,472,000 after purchasing an additional 487,442 shares in the last quarter. Institutional investors and hedge funds own 84.03% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Story: How to Invest in Marijuana Stocks

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply